…
FA 2002, s. 54
Tax relief for expenditure on vaccine research etc
In forcesince 1 Apr 2009cited 1×
Changed on 1 Apr 2009
(1) Schedule 13 to this Act (which makes provision for tax relief for companies’ expenditure on vaccine research etc) has effect.
(2) Schedule 14 to this Act (which makes provision consequential on Schedule 13) has effect.…
- 1 Apr 2009 – todayin force
- 24 Jul 2002 – 1 Apr 2009earlier wording